NEUROMYELITIS OPTICA side effect
What is NEUROMYELITIS OPTICA ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
NEUROMYELITIS OPTICA and Recently Reported Side Effects
NEUROMYELITIS OPTICA and 15 most Active Side Effect polls
NEUROMYELITIS OPTICA and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Tysabri Side Effects Report #5651837-2
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Feb 19, 2008. Female patient, 54 years of age, weighting 167.0 lb, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . TYSABRI dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5691292-X
TYSABRI problem was reported by a Physician from UNITED STATES on Mar 18, 2008. Female patient was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with AVONEX. Patient recovered.
Tysabri Side Effects Report #5621672-X
Physician from UNITED STATES reported TYSABRI problem on Jan 21, 2008. Female patient was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with AVONEX. Patient recovered.
Rebif Side Effects Report #5643967-6
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2008. Male patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
Rebif Side Effects Report #5575268-9
Consumer or non-health professional from UNITED STATES reported REBIF problem on Dec 18, 2007. Female patient, 48 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, respiratory failure, . REBIF dosage: unknown. Patient died on 04/16/2007.
Rebif Side Effects Report #5465316-9
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2007. Female patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5470301-7
Health Professional from UNITED STATES reported NATALIZUMAB problem on Sept 10, 2007. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
Strattera Side Effects Report #5383353-X
STRATTERA problem was reported by a Physician from IRELAND on June 27, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . STRATTERA dosage: 25 MG, DAILY (1/D). During the same period patient was treated with CONCERTA. Patient was hospitalized. Patient recovered.
Strattera Side Effects Report #5388422-6
Physician from IRELAND reported STRATTERA problem on July 03, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, vertebral column mass, . STRATTERA dosage: 25 MG, DAILY (1/D). During the same period patient was treated with CONCERTA. Patient was hospitalized. Patient recovered.
Strattera Side Effects Report #5383353-X
STRATTERA problem was reported by a Physician from IRELAND on June 27, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . STRATTERA dosage: 25 MG, DAILY (1/D). During the same period patient was treated with CONCERTA. Patient was hospitalized. Patient recovered.
Strattera Side Effects Report #5388422-6
Physician from IRELAND reported STRATTERA problem on July 03, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, vertebral column mass, . STRATTERA dosage: 25 MG, DAILY (1/D). During the same period patient was treated with CONCERTA. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5701745-3
TYSABRI problem was reported by a Health Professional from UNITED STATES on Apr 01, 2008. Female patient, 54 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
Rebif Side Effects Report #5333290-1
Consumer or non-health professional from UNITED STATES reported REBIF problem on May 08, 2007. Male patient, 25 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . REBIF dosage: unknown. During the same period patient was treated with TRICOR. Patient was hospitalized. Patient recovered.
Strattera Side Effects Report #5304810-8
STRATTERA problem was reported by a Physician from IRELAND on Apr 11, 2007. Male patient, 16 years of age, was diagnosed with attention deficit/hyperactivity disorder and was treated with STRATTERA. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . STRATTERA dosage: 25 MG, DAILY (1/D). During the same period patient was treated with CONCERTA. Patient was hospitalized. Patient recovered.
Rebif Side Effects Report #5678695-4
Consumer or non-health professional from UNITED STATES reported REBIF problem on Mar 11, 2008. Male patient, 24 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . REBIF dosage: unknown. During the same period patient was treated with ADVAIR, ALBUTEROL INHALER. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5680981-9
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 13, 2008. Female patient, 25 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, neuromyelitis optica, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5606900-9
Consumer or non-health professional from UNITED STATES reported TYSABRI problem on Jan 18, 2008. Female patient, 33 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis, neuromyelitis optica, quadriplegia, rash, refusal of treatment by patient, urinary retention, urinary tract infection, urticaria, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient died on 12/30/2005.
Tysabri Side Effects Report #5607488-9
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2008. Female patient, 33 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis, neuromyelitis optica, paralysis, . TYSABRI dosage: unknown. During the same period patient was treated with REBIF. Patient was hospitalized. Patient died on 12/30/2005.
Natalizumab Side Effects Report #5549561-X
Health Professional from UNITED STATES reported NATALIZUMAB problem on Nov 30, 2007. Female patient, 63 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis relapse, neuromyelitis optica, no therapeutic response, pneumonia, urinary tract infection, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with LEVOXYL, BONIVA, AMBIEN, NOVANTRONE. Patient was hospitalized. Patient died on 07/01/2007.
Natalizumab Side Effects Report #5523132-3
NATALIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 12, 2007. Female patient, 58 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: delirium, neuromyelitis optica, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient died on 01/01/2007.
Tysabri Side Effects Report #5483831-9
Health Professional from UNITED STATES reported TYSABRI problem on Oct 02, 2007. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: myelitis, neuromyelitis optica, . TYSABRI dosage: 300 MG;QM; IV. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5493908-X
NATALIZUMAB problem was reported by a Physician from UNITED STATES on Oct 10, 2007. Female patient, 40 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis relapse, neuromyelitis optica, paraparesis, . NATALIZUMAB dosage: 300 MG;QM;IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5392973-8
Consumer or non-health professional from UNITED STATES reported AVONEX problem on July 09, 2007. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis relapse, neuromyelitis optica, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5392973-8
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis relapse, neuromyelitis optica, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5712051-5
Physician from UNITED STATES reported AVONEX problem on Apr 07, 2008. Female patient, 25 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: condition aggravated, neuromyelitis optica, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Avonex Side Effects Report #5360414-2
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on June 04, 2007. Female patient, 55 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
Rebif Side Effects Report #5320530-8
Consumer or non-health professional from UNITED STATES reported REBIF problem on Apr 20, 2007. Male patient, 42 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuromyelitis optica, urinary incontinence, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
Rebif Side Effects Report #5277638-5
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 29, 2007. Female patient, 37 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: neuralgia, neuromyelitis optica, . REBIF dosage: unknown. During the same period patient was treated with TEGRETOL. Patient recovered.
Rebif Side Effects Report #5794329-2
Consumer or non-health professional from UNITED STATES reported REBIF problem on June 12, 2008. Female patient, 46 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: hepatomegaly, hypertension, neuromyelitis optica, oedema peripheral, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
Natalizumab Side Effects Report #5361634-3
NATALIZUMAB problem was reported by a Pharmacist from UNITED STATES on June 07, 2007. Female patient, 58 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: delirium, demyelination, neuromyelitis optica, pneumonia, quadriplegia, respiratory failure, spinal cord disorder, . NATALIZUMAB dosage: 300 MG; QM; IV. During the same period patient was treated with AVONEX. Patient was hospitalized. Patient recovered.
Rebif Side Effects Report #5307748-5
Consumer or non-health professional from UNITED STATES reported REBIF problem on Apr 09, 2007. Female patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: coordination abnormal, hypoaesthesia, neuromyelitis optica, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
Rebif Side Effects Report #5276644-4
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2006. Male patient, 25 years of age, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: multiple sclerosis relapse, nervous system disorder, neuromyelitis optica, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.